Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study Assessing the REG1 Anticoagulation System Compared Heparin in Subjects With Acute Coronary Syndrome (RADAR)

This study has been completed.
Information provided by (Responsible Party):
Regado Biosciences, Inc. Identifier:
First received: July 1, 2009
Last updated: March 1, 2012
Last verified: March 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2011
  Primary Completion Date: January 2011 (Final data collection date for primary outcome measure)
TCT-176: Access and non-Access Site Bleeding in Acute Coronary Syndrome Patients Treated with a Novel Actively Reversible Factor IXa Inhibitor. Results from the RADAR Trial J Am Coll Cardiol 2011 58: B47

Publications automatically indexed to this study by Identifier (NCT Number):